BARNSTABLE, Mass., April 3, 2013 /PRNewswire/ -- UV Flu
Technologies, Inc. (OTCQB: UVFT)(the "Company") announced today
that the Company is forecasting that this year may the worst
allergy season ever, particularly in the Northeast, as well as many
northern states.
"This Winter has conditions in place for a horrible allergy
season," said Jack Lennon, President
of UV Flu Technologies. "Record snowfalls in many of the 48 states
this season that did get snow, not only put in place high levels of
moisture, but record levels of nitrogen, which stimulates plant
growth in a fertilizer-like fashion. When added to the warmer
global temperatures, longer allergy season, and higher CO2 levels,
we expect record levels of pollen, mold and mildew, particularly
acute in areas that were impacted by Hurricane Sandy," said Mr.
Lennon
"We highly recommend a high quality air purifier, like our
ViraTech UV-400, to the over 50 million Americans that suffer from
allergy and asthma symptoms. Although our device is
filter-less, and treats almost all forms of indoor air pollution,
including smoke and toxic chemicals, it is very important that
users of filter-based technologies change their filters regularly,
as the filter mediums can become infected, and actually make
allergies worse," said Mr. Lennon.
"Consumers are just beginning to recognize that the purchase of
a high quality air purifier may be the most cost-effective purchase
they've ever made for the health and safety of their entire family,
particularly families with asthma, allergies, or other medical
conditions. No one would ever allow their children to drink water
they knew to be contaminated, yet the toxic air they breathe daily
in their home is left untreated. Ninety-eight percent of consumers
that purchase our ViraTech UV-400 air purifier report dramatically
reduced levels of allergy symptoms, along with better sleep at
night."
"Our 1st quarter sales increased 75%, but we expect
growth rates two to three times this rate for the second and third
quarter of this year. With this in mind, we are adding Mr.
Glenn Bushee, President of
Brite-Strike Technologies, to our Board of Directors. Mr. Bushee's
extensive experience in marketing and production will be of immense
value to our Company," said Mr. Lennon.
Further details regarding the Company's business, acquisitions,
financial reports and agreements are filed as part of the Company's
continuous public disclosure as a reporting issuer under the
Securities Exchange Act of 1934 filed with the Securities and
Exchange Commission's ("SEC") EDGAR database. For more
information, visit: www.uvflutech.com, and click on the 5 minute
video describing the ViraTech UV-400.
About UV Flu Technologies, Inc. (OTCQB: UVFT)
UV Flu
Technologies is an innovative developer; manufacturer and
distributor of bio technology products initially targeting the
rapidly growing Indoor Air Quality ("IAQ") industry sector
($7 billion in 2011). The Company
manufactures the ViraTech UV-400, which utilizes high-intensity
ultraviolet radiation (UV-C) inside a killing chamber that goes
beyond filtration to destroy harmful airborne bacteria, at rates
exceeding 99.2% on a first-pass basis, while also reducing the
concentrations of odors, and VOC's (volatile organic compounds,
such as acetone, benzene, formaldehyde, etc.) The FDA has
issued a coveted Class II medical listing that enables UV Flu
Technologies to market the product as a medical device. For more
information, visit: www.uvflutech.com.
Notice Regarding Forward-Looking Statements
This news
release contains "forward-looking statements" as that term is
defined in Section 27A of the United States Securities Act of 1933,
as amended and Section 21E of the Securities Exchange Act of 1934,
as amended. Statements in this press release which are not purely
historical are forward-looking statements and include any
statements regarding beliefs, plans, expectations or intentions
regarding the future. Such forward-looking statements include,
among other things, the development, costs and results of new
business opportunities. Actual results could differ from those
projected in any forward-looking statements due to numerous
factors. Such factors include, among others, the inherent
uncertainties associated with new projects and development stage
companies. These forward-looking statements are made as of the date
of this news release, and we assume no obligation to update the
forward-looking statements, or to update the reasons why actual
results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans,
expectations and intentions contained in this press release are
reasonable, there can be no assurance that any such beliefs, plans,
expectations or intentions will prove to be accurate. Investors
should consult all of the information set forth herein and should
also refer to the risk factors disclosure outlined in our annual
report on Form 10-K for the most recent fiscal year, our quarterly
reports on Form 10-Q and other periodic reports filed from
time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies,
Inc.
-----------------------------
John J. Lennon, President &
CEO
Investor Information:
Toll-Free: 1-877-358-5545
(FLU-KILL)
Web: www.uvflutech.com
Retail or Internet Inquires:
Please call our Corporate
Office at: 508-362-5455
SOURCE UV Flu Technologies, Inc.